Buyer
NHS England
Sector
Pharmaceutical products
Awarded To
Norgine Pharmaceuticals Limited, Rayner Surgical Group Ltd, Napp Pharmaceuticals Ltd, Gedeon Richter UK Ltd, Tillomed Laboratories ltd, Alissa Healthcare Research Limited, Novartis Pharmaceuticals UK Ltd, Eisai Ltd, Aspen Pharmacare UK Limited, Ferring Pharmaceuticals Ltd, Theramex HQ UK, G.L. Pharma UK Limited, Ridge Pharma, Nordic Pharma, Strandhaven Ltd t/a Somex Pharma, Xiromed, Novo Nordisk, Esteve Pharmaceuticals Ltd, Aventis Pharma ltd t/a Sanofi, Galen Limited, Grunenthal, Drugsrus Ltd, SERB SA, Orifarm UK, Merck Serono Limited, Astellas Pharma Ltd, Besins Healthcare UK LTD, Dexcel Pharma Ltd, Pharmasure, Ipsen, Janssen-Cilag Ltd, Pharming Group, Baxter Healthcare Ltd, Chiesi Limited, Otsuka Pharmaceuticals UK Limited, CST Pharma Limited, Selective Supplies Ltd., Glenmark Pharmaceuticals Europe Limited, Wockhardt UK Limited, ROVI Biotech Ltd, Essential Pharma, Bayer Plc, BioCryst Ireland Limited, Kyowa Kirin International UK New Co Ltd, Neuraxpharm UK Ltd, Organon Pharmaceuticals UK Ltd, Provepharm UK Ltd, Colonis Pharma Ltd, Accord-UK Ltd, Neon Healthcare Ltd, Sun Pharma UK Ltd, Sandoz Ltd, Teva UK Limited, Recordati Rare Diseases UK Ltd, medac Pharma LLP, Synchrony, INFECTOPHARM LTD, Mercury Pharmaceuticals Limited, Merz, Pfizer Ltd, Takeda UK Ltd, Aspire Pharma Limited, Zentiva Pharma UK Ltd, Day Lewis Medical Ltd, Morningside Pharmaeuticals, Celix Pharma Ltd., Lupin Healthcare (UK) Limited, Abbvie Ltd, Mylan, CSL Behring UK Ltd, FLYNN PHARMA LTD, Thornton and Ross Ltd
Status
complete
Published
22 Apr 2025, 15:48